Lactobacillus Plantarum for Psoriasis: Safety and Effectiveness Study
Part of Skin clinical trials.
This trial tests whether a probiotic called Lactobacillus plantarum can safely help treat psoriasis. It's a randomized, double-blind study where some participants get the probiotic and others get a placebo, so no one knows who gets what.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have mild to moderate psoriasis with a PASI score less than 10.
- You are between 18 and 60 years old and in good general health.
- You have not taken any psoriasis medications in the last 6 months.
- You do not have other inflammatory skin diseases, infections, or neuromuscular diseases.
- You are not in the active phase of another skin disease or have other serious illnesses.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how safe and how the body handles (pharmacokinetics) a psoriasis lotion called IDP-122 when used in children with plaque psoriasis. You may be able to join if your child has a suitable amount of plaque psoriasis and can follow safety rules during the study.
This study looks at whether changes in gut bacteria are linked to psoriasis flare-ups after stopping certain biologic treatments. It may help understand why some people relapse after stopping medication.
This trial tests a new medication, CBP-0276, to see if it improves psoriasis symptoms and quality of life. It is for people with moderate to severe plaque psoriasis who might need stronger treatment.
This study looks at fungi (yeasts) on the skin and in the gut to understand how they might trigger or worsen psoriasis. It involves people with psoriasis, people having plastic surgery, and household members of those with psoriasis.
This study tests whether a new ointment called RSS0393 can safely and effectively treat plaque psoriasis (a common skin condition causing red, scaly patches). You would apply it to affected skin areas and be compared to people using a placebo (inactive cream) to see if the treatment works.
This trial tests a new study drug (ZP9830) to see if it is safe and works well for people with plaque psoriasis. You would receive the treatment for 8 weeks, and the study will check how your skin responds.
Hear when a new Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.